Extended Data Fig. 8: Downgrading and Upgrading of GGG after whole-mount histopathological analysis, According to Biopsy and MRI-PTPCa.
From: An MRI–pathology foundation model for noninvasive diagnosis and grading of prostate cancer
a) Distribution of up- and down-grading in pathological evaluation of biopsy tissue. b) Distribution of up- and down-grading in prediction of MRI-PTPCa. The n(%) indicated on the diagram represents numbers of patients and ratios.
